{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The test compounds were tested on the same microtiterplate in 1 1 different concentrations in the range of 20 \u03bc\u039c to 0.1 nM (20 \u03bc\u039c, 5.9 \u03bc\u039c, 1 .7 \u03bc\u039c, 0.51 \u03bc\u039c, 0.15 \u03bc\u039c, 44 nM, 13 nM, 3.8 nM, 1 .1 nM, 0.33 nM and 0.1 nM, the dilution series prepared separately before the assay on the level of the 100fold concentrated solutions in DMSO by serial 1 :3.4 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit.\n* Then the kinase reaction was started by the addition of 3 \u03bc\u03af of a solution of adenosine-triphosphate (ATP, 16.7 \u03bc\u039c =&gt; final cone, in the 5 \u03bc\u0399_ assay volume is 10 \u03bc\u039c) and substrate (2.27 \u03bcg/mL =&gt; final cone, in the 5 \u03bc\u03af. assay volume is 1 .36 \u03bcg/mL [- 30 nM]) in assay buffer and the resulting mixture was incubated for a react \n\nNote that there are limited sentences that meet the criteria, as the text primarily describes methods and procedures. The extracted sentences provide specific details about the concentrations of test compounds and the kinase reaction."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": null, "value": "16.7", "unit": "\u03bc\u039c"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bc\u039c"}, {"molecule_name": "substrate", "protein_target_name": null, "binding_metric": null, "value": "2.27", "unit": "\u03bcg/mL"}, {"molecule_name": "substrate", "protein_target_name": null, "binding_metric": null, "value": "1.36", "unit": "\u03bcg/mL"}, {"molecule_name": "substrate", "protein_target_name": null, "binding_metric": null, "value": "30", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The resulting mixture was incubated 1 h at 22 C to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XLent and the PT66-Eu- Chelate with an IC50 value of 1.4 nM.\n* Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 \u03bc to 1 nM (20 \u03bc , 6.7 \u03bc\u039c, 2.2 \u03bc\u039c, 0.74 \u03bc\u039c, 0.25 \u03bc\u039c, 82 \u03b7\u039c, 27 \u03b7\u039c, 9.2 \u03b7\u039c, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100fold cone, stock solutions by serial 1 :3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit.\n* Then the kinase reaction was started by the addition of 3 \u03bc\u03af of a solution of adenosine-tri-phosphate (ATP, 16.7 \u03bc\u039c =&gt; final cone, in the 5 \u03bc\u03af. assay volume is 10 \u03bc\u039c) and substrate (2 \u03bc\u039c =&gt; final cone, in the 5 \u03bc\u0399_ assay volume is 1 .2 \u03bc\u039c) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C.\n* As substrate for the kinase reaction the biotinyiated peptide biotin-KVEKIGEGTYGW (C-terminus in amid form) was used which can be purchased e.g. form the company Biosynthan GmbH (Berlin-Buch, Germany) with a concentration of 2 \u03bc\u039c =&gt; final cone, in the 5 \u03bc\u0399_ assay volume is 1 .2 \u03bc\u039c."}
{"final_json": [{"molecule_name": "biotinylated phosphorylated peptide", "protein_target_name": null, "binding_metric": "IC50", "value": "1.4", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "adenosine-tri-phosphate (ATP)", "protein_target_name": null, "binding_metric": null, "value": "16.7", "unit": "\u03bc\u039c"}, {"molecule_name": "biotin-KVEKIGEGTYGW", "protein_target_name": null, "binding_metric": null, "value": "2", "unit": "\u03bc\u039c"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The data were normalised (enzyme reaction without inhibitor = 0 % inhibition, all other assay components but no enzyme = 100 % inhibition) and IC50 values were calculated by a 4 parameter fit for test compound concentrations in the range of 20 \u03bc\u039c to 1 nM.\n* Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 \u03bc\u039c to 1 nM (20 \u03bc\u039c, 6.7 \u03bc\u039c, 2.2 \u03bc\u039c, 0.74 \u03bc\u039c, 0.25 \u03bc\u039c, 82 \u03b7\u039c, 27 \u03b7\u039c, 9.2 \u03b7\u039c, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100fold cone, stock solutions by serial 1 :3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit.\n* Then the kinase reaction was started by the addition of 3 \u03bc\u0399_ of a solution of adenosine-triphosphate (ATP, 16.7 \u03bc\u039c =&gt; final cone, in the 5 \u03bc\u03af assay volume is 10 \u03bc\u039c) and substrate (2.27 \u03bcg/mL =&gt; final cone, in the 5 \u03bc\u0399_ assay volume is 1 .36 \u03bcg/ml [- 30 nM]) in assay buffer and the resulting mixture was incubated for a reaction time of \n\nNote that the sentences may not explicitly mention a specific molecule name, but they contain information about the bioactivity metric (IC50), numeric value, and unit, which are relevant to the task."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": "nM"}, {"molecule_name": "adenosine-triphosphate (ATP)", "protein_target_name": "kinase", "binding_metric": null, "value": "16.7", "unit": "\u03bc\u039c"}, {"molecule_name": "substrate", "protein_target_name": "kinase", "binding_metric": null, "value": "2.27", "unit": "\u03bcg/mL"}, {"molecule_name": "substrate", "protein_target_name": "kinase", "binding_metric": null, "value": "30", "unit": "nM"}]}
